Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Role of intravitreal bevacizumab in neovascular glaucoma.
- M. Gheith, G. Siam, D. D. de Barros, S. Garg, M. Moster
- MedicineJournal of ocular pharmacology and therapeutics…
- 17 October 2007
It is suggested that IVB may be a valuable addition in the treatment of NVG by hastening the resolution of anterior segment neovascularization, improving the results of glaucoma surgeries, and appears to give long-term control when used in combination with PRP.
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Retinal pigment epithelial tear after intravitreal bevacizumab injection.
Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis.
- D. Remick, S. Garg, D. Newcomb, G. Wollenberg, T. Huie, G. Bolgos
- Medicine, BiologyCritical care medicine
- 1 May 1998
Exogenous IL-10 fails to improve morbidity or mortality in the clinically relevant cecal ligation and puncture model of sepsis, and is indicated to reduce the appearance of TNF or IL-6 in the plasma or peritoneal fluid.
Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Refractive Outcomes after Pars Plana Vitrectomy and Scleral Fixated Intraocular Lens with Gore-Tex Suture.
Optical coherence tomography of chronic solar retinopathy.
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
COMBINED PARS PLANA VITRECTOMY AND SCLERAL FIXATION OF AN INTRAOCULAR LENS USING GORE-TEX SUTURE: One-Year Outcomes
Combined pars plana vitrectomy and ab externo scleral fixation of an intraocular lens with Gore-Tex suture was well tolerated at a minimum of 1-year follow-up and no suture-related complications were encountered.
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
It is suggested that topical dorzolamide-timolol may reduce central subfield thickness and subretinal fluid in eyes with persistent exudation despite consistent, fixed-interval intravitreous anti-VEGF treatment for neovascular AMD.